Non-alcoholic fatty liver disease

46,140views

Non-alcoholic fatty liver disease

Gastroenterology

Gastroenterology

Diverticular disease: Pathology review
Malabsorption syndromes: Pathology review
Colorectal polyps and cancer: Pathology review
Peptic ulcers and stomach cancer: Clinical
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Gastric cancer
Anatomy of the abdominal viscera: Small intestine
Anatomy of the abdominal viscera: Large intestine
Intestinal atresia
Intestinal fluid balance
Intestinal adhesions
Intestinal malrotation
Inflammatory bowel disease: Clinical
Bowel obstruction
Small bowel ischemia and infarction
Irritable bowel syndrome
Inflammatory bowel disease: Pathology review
Small bowel bacterial overgrowth syndrome
Congenital gastrointestinal disorders: Pathology review
Peutz-Jeghers syndrome
Alcohol-associated liver disease
Liver anatomy and physiology
Liver histology
Benign liver tumors
Cholestatic liver disease
Non-alcoholic fatty liver disease
Hepatic encephalopathy
Wilson disease
Cirrhosis
Gastrointestinal system anatomy and physiology
Cystic fibrosis: Pathology review
Enteric nervous system
Bowel obstruction: Clinical
Ruptured spleen
Colorectal cancer
Colorectal cancer: Clinical
Antimetabolites for cancer treatment
Oral cancer
Abdominal pain: Clinical
Achalasia
Esophageal disorders: Clinical
Esophageal disorders: Pathology review
Esophageal surgical conditions: Clinical
Esophageal cancer
Gastroesophageal reflux disease (GERD): Clinical
Dyslipidemias: Pathology review
Ascending cholangitis
Primary sclerosing cholangitis
Cirrhosis: Pathology review
Jaundice: Clinical
Primary biliary cholangitis
Jaundice: Pathology review
Gallbladder disorders: Clinical
Cirrhosis: Clinical
Pancreatitis: Clinical
Pediatric gastrointestinal bleeding: Clinical
Superior mesenteric artery syndrome
Ischemia
Ischemic colitis
Gastrointestinal bleeding: Pathology review
Gastrointestinal bleeding: Clinical
Alcohol use disorder
Fetal alcohol syndrome
Pancreatitis: Pathology review
Wernicke-Korsakoff syndrome
Gluconeogenesis
Anorexia nervosa
Eating disorders: Clinical
Eating disorders: Pathology review
Bulimia nervosa
Pancreatic cancer
Pediatric vomiting: Clinical
Zinc deficiency and protein-energy malnutrition: Pathology review
Hepatitis A and Hepatitis E virus
Appendicitis: Clinical
Appendicitis
Appendicitis: Pathology review
Short bowel syndrome (NORD)
Intussusception
Gallstone ileus
Hernias: Clinical
Volvulus
Diverticular disease: Clinical
Non-Hodgkin lymphoma
Diarrhea: Clinical
Celiac disease
Celiac disease: Nursing process (ADPIE)
Tropical sprue
Biliary colic
Malabsorption: Clinical
Food allergy
Vibrio cholerae (Cholera)
Antidiarrheals
Salmonellosis
Clostridium botulinum (Botulism)
Clostridium perfringens
Clostridium difficile (Pseudomembranous colitis)
Diffuse esophageal spasm
Small intestine histology
Peptic ulcer
Gastric motility
Zollinger-Ellison syndrome
Gallbladder histology
Helicobacter pylori
Pancreatic secretion
Chronic pancreatitis
Pyloric stenosis
Esophageal web
Esophageal motility
Boerhaave syndrome
Esophagitis: Clinical
Laxatives and cathartics
Anal conditions: Clinical
Abdominal hernias
Inguinal hernia
Femoral hernia
Congenital diaphragmatic hernia
Omphalocele
Gastroparesis: Clinical
Gastroparesis
Gallbladder carcinoma
Viral hepatitis
Hepatitis medications
Hepatitis B and Hepatitis D virus
Viral hepatitis: Clinical
Neonatal hepatitis
Hepatitis C virus
Viral hepatitis: Pathology review
Autoimmune hepatitis
Hepatitis D virus
Hepatitis B and Hepatitis D virus
Prions (Spongiform encephalopathy)
Portal hypertension
Hepatocellular carcinoma
Hepatocellular adenoma
Neonatal jaundice: Clinical
Hirschsprung disease
Mallory-Weiss syndrome
Meckel diverticulum
Childhood nutrition and obesity: Information for patients and families (The Primary School)
Rectal prolapse
Pediatric constipation: Clinical
Ulcerative colitis
Familial adenomatous polyposis
Colorectal polyps
Vitamin B12 deficiency
Peritonitis
Abdominal trauma: Clinical
Enterobacter
Cystic fibrosis: Clinical
Acute cholecystitis
Microscopic colitis

Transcript

Watch video only

Nonalcoholic fatty liver disease is actually a spectrum of disease, going from least to most severe—steatosis, steatohepatitis, fibrosis, and finally cirrhosis.

Nonalcoholic fatty liver disease results from fat deposition in the liver, which is unrelated to alcohol or viral causes.

Typically, it affects individuals with metabolic syndrome, which includes a combination of three of the following five diagnoses: obesity, hypertension, diabetes, hypertriglyceridemia, and hyperlipidemia.

Given how common metabolic syndrome has become, it’s not surprising that the rate of nonalcoholic fatty liver disease has also increased dramatically.

It’s a massive problem growing in lock-step with expanding waistlines, affecting about three quarters of all obese individuals, including many children.

Although the exact mechanism of nonalcoholic fatty liver disease isn’t clear, insulin resistance seems to play an important role.

Over time, insulin receptors on various tissues including the liver become less responsive to insulin, and as a result the liver goes into a mode where it increases fat storage and decreases fatty acid oxidation.

That means decreased secretion of lipids into the bloodstream, in the form of lipoproteins, and increased synthesis and uptake of free fatty acids from the blood, a process called steatosis.

Steatosis causes fat droplets to form within hepatocytes, some of which become large enough to cause the hepatocytes to swell up with fat and push the nuclei to the edge of the cell.

You can see this on a histopathology slide of the liver.

All of these white circles are large deposits of fat.

Zooming out and looking at the liver, you see widespread steatosis which makes the liver appear large, soft, yellow, and greasy.

Over time, that fat in the hepatocytes is vulnerable to degradation.

Unsaturated fatty acids, or fatty acids that have at least one double bond in their carbon chain, have hydrogen atoms that are especially vulnerable to initiators such as the reactive oxygen species like the hydroxyl radical that have an unpaired electron.

In this example the hydroxyl radical pairs with the vulnerable lipid hydrogen to make water and a fatty acid radical.

The fatty acid radical is unstable and reacts with non-radicals, including molecular oxygen and undamaged fatty acids.

This goes on until one radical species reacts with another radical species, which terminates the reaction.

This process damages lipid membranes leading to things like mitochondrial dysfunction and eventually cell death.

Cell death generates inflammation, and together the process of steatosis and inflammation is referred to as steatohepatitis.

In the absence of alcohol this is called nonalcoholic steatohepatitis or NASH.

Key Takeaways

Non-alcoholic fatty liver disease (NAFLD) is a condition in which excess fat is deposited in the liver, leading to inflammation and scarring. NAFLD is a common liver disorder that affects people who do not drink alcohol excessively. NAFLD commonly affects people with metabolic syndrome, which includes a combination of three of the following five diagnoses: obesity, hypertension, diabetes, hypertriglyceridemia, and hyperlipidemia.

Symptoms of NAFLD may be subtle or absent in the early stages of the disease. In advanced stages, symptoms may include fatigue, abdominal pain, and jaundice. NAFLD can progress to a more serious condition called non-alcoholic steatohepatitis (NASH), which can lead to liver scarring and cirrhosis. Treatment for NAFLD may involve lifestyle changes such as weight loss, regular exercise, and a healthy diet to help reduce fat in the liver and improve insulin resistance.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
  5. "The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease" Nutrients (2014)
  6. "Non-alcoholic fatty liver disease" BMJ (2014)